Showing results (51-60 of 293) with videos related to
Sort By:
Pageof 30
Journal of Immunology (Baltimore, Md. : 1950)|November 17, 2016
Overexpression of Soluble Fas Ligand following Adeno-Associated Virus Gene Therapy Prevents Retinal Ganglion Cell Death in Chronic and Acute Murine Models of GlaucomaAnitha Krishnan, Fei Fei, Alexander Jones, et al.Nature|April 12, 2002
Chromatin-IgG complexes activate B cells by dual engagement of IgM and Toll-like receptorsElizabeth A Leadbetter, Ian R Rifkin, Andreas M Hohlbaum, et al.Journal of Immunology (Baltimore, Md. : 1950)|August 24, 2002
Membrane Fas ligand activates innate immunity and terminates ocular immune privilegeMeredith S Gregory, Amanda C Repp, Andreas M Holhbaum, et al.Journal of Immunology (Baltimore, Md. : 1950)|October 30, 2009
Differential cytokine production and bystander activation of autoreactive B cells in response to CpG-A and CpG-B oligonucleotidesAna M Avalos, Eicke Latz, Betty Mousseau, et al.Investigative Ophthalmology & Visual Science|June 28, 2005
A novel treatment for ocular tumors using membrane FasL vesicles to activate innate immunity and terminate immune privilegeMeredith S Gregory, Sean Koh, Eric Huang, et al.Immunohorizons|August 9, 2023
Disease in the Pld4thss/thss Model of Murine Lupus Requires TLR9Amanda L Gavin, Tanya R Blane, Therese C Thinnes, et al.Immunity|December 13, 2003
Activation of autoreactive B cells by CpG dsDNAGregory A Viglianti, Christina M Lau, Timothy M Hanley, et al.Journal for Immunotherapy of Cancer|November 21, 2018
Immunoregulatory functions of innate lymphoid cellsSarah Q Crome, Pamela S OhashiAnnals of the New York Academy of Sciences|May 9, 2013
Molecular programming of steady-state dendritic cells: impact on autoimmunity and tumor immune surveillanceDylan J Johnson, Pamela S OhashiImmunity|April 13, 2022
DC1s shield Tpex cells to bolster PD-1 blockadeDavid G Brooks, Pamela S OhashiPageof 30